Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical Characteristics and Outcomes of Patients with Primary and Secondary Myelofibrosis According to the Genomic Classification Using Targeted Next-Generation Sequencing.
Garrote M, López-Guerra M, Arellano-Rodrigo E, Rozman M, Carbonell S, Guijarro F, Santaliestra M, Triguero A, Colomer D, Cervantes F, Álvarez-Larrán A. Garrote M, et al. Cancers (Basel). 2023 Jul 31;15(15):3904. doi: 10.3390/cancers15153904. Cancers (Basel). 2023. PMID: 37568719 Free PMC article.
[Subcutaneous panniculitic T-cell lymphoma].
Alvarez-Larrán A, López-Guillermo A, Miquel R, Montserrat E. Alvarez-Larrán A, et al. Med Clin (Barc). 1999 Jun 26;113(3):117. Med Clin (Barc). 1999. PMID: 10464748 Spanish. No abstract available.
Lack of negative impact of Philadelphia chromosome in older patients with acute lymphoblastic leukaemia in the thyrosine kinase inhibitor era: comparison of two prospective parallel protocols.
Ribera JM, García O, Fernández-Abellán P, Lavilla E, Bernal MT, González-Campos J, Brunet S, Monteserín MC, Montesinos P, Sarrá J, Calbacho M, Alvarez-Larrán A, Tormo M, Oriol A; PETHEMA Group. Ribera JM, et al. Br J Haematol. 2012 Nov;159(4):485-8. doi: 10.1111/bjh.12043. Epub 2012 Sep 12. Br J Haematol. 2012. PMID: 22966847 Free article. Clinical Trial. No abstract available.
Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients.
Peñalver FJ, Jiménez-Yuste V, Almagro M, Alvarez-Larrán A, Rodríguez L, Casado M, Gallur L, Giraldo P, Hernández R, Menor D, Rodríguez MJ, Caballero D, González R, Mayans J, Millán I, Cabrera JR; Multi-institutional Retrospective Spanish Study Group on the Use of Rituximab in Refractory ITP. Peñalver FJ, et al. Ann Hematol. 2006 Jun;85(6):400-6. doi: 10.1007/s00277-005-0073-1. Epub 2006 Mar 21. Ann Hematol. 2006. PMID: 16550390
163 results